PPARγ stimulation improves cardiovascular risk profile independent from its glucose lowering effects

被引：0
|
作者：
Hohberg, C
Lübben, G
Forst, T
Marx, N
Weber, MM
Löbig, M
Pfützner, A
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A149 / A150
页数：2
相关论文
共 50 条
  • [31] The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes
    Sosnowski, Cezary
    Janeczko-Sosnowska, Ewa
    KARDIOLOGIA POLSKA, 2008, 66 (09) : 1013 - 1019
  • [32] Dairy Foods: Is Its Cardiovascular Risk Profile Changing?
    Nestel, Paul J.
    Mori, Trevor A.
    CURRENT ATHEROSCLEROSIS REPORTS, 2022, 24 (01) : 33 - 40
  • [33] Dairy Foods: Is Its Cardiovascular Risk Profile Changing?
    Paul J. Nestel
    Trevor A. Mori
    Current Atherosclerosis Reports, 2022, 24 : 33 - 40
  • [34] Cardiovascular risk profile in high risk primary care patients not treated with lipid-lowering treatment
    Dallongeville, J.
    Bruckert, E.
    Ferrieres, J.
    Delaage, P. H.
    Thomas-Delecourt, F.
    Bonnelye, G.
    Kownator, S.
    EUROPEAN HEART JOURNAL, 2012, 33 : 127 - 127
  • [35] Glucose intolerance as independent risk factor for cardiovascular disease in obese children
    Körner, A
    Csillag, J
    Pintér, A
    DIABETOLOGIA, 2004, 47 : A210 - A211
  • [36] Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes REPLY
    Kalyani, Rita R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (07): : 671 - 672
  • [37] Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes
    Patti, Angelo Maria
    Rizvi, Ali A.
    Giglio, Rosaria Vincenza
    Stoian, Anca Pantea
    Ligi, Daniela
    Mannello, Ferdinando
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
  • [38] PPARγ Agonists and Vascular Risk Factors: Potential Effects on Cardiovascular Disease
    Asnani, Sunil
    Theuma, Pierre
    Fonseca, Vivian A.
    METABOLIC SYNDROME AND RELATED DISORDERS, 2003, 1 (01) : 23 - 32
  • [39] Hypoxia effect on the hepatic profile, glucose metabolism and cardiovascular risk.
    Aldave Orzaiz, Beatriz
    Landete Rodriguez, Pedro
    Acosta Gutierrez, Carmen
    Hernandez Olivo, Marta
    Gonzalez Gonzalez, Maria
    Munoz Olmedo, Jose Manuel
    Friera Reyes, Alfonsi
    Sanchez Azofra, Ana
    Zamora Garcia, Enrique
    Gonzalez Rodriguez, Agueda
    Soriano, Joan B.
    Garcia Monzon, Carmelo
    Ancochea Bermudez, Julio
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [40] Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk
    Rozalina G. McCoy
    Jeph Herrin
    Kavya Sindhu Swarna
    Yihong Deng
    David M. Kent
    Joseph S. Ross
    Guillermo E. Umpierrez
    Rodolfo J. Galindo
    William H. Crown
    Bijan J. Borah
    Victor M. Montori
    Juan P. Brito
    Joshua J. Neumiller
    Mindy M. Mickelson
    Eric C. Polley
    Nature Cardiovascular Research, 2024, 3 : 431 - 440
12345